Back to Studies

P1084s / Maternal Infant TDF Toxicity Safety

Maternal and Infant Monitoring for Evidence of Toxicity Related to Tenofovir Exposure: The Bone and Kidney Health Substudy of PROMISE Protocol: Promoting Maternal and Infant Survival Everywhere

Study Status

Closed to Follow Up

DAIDS Number

10790

IND Number

107,547

Clinical Trials Link

DAIDS Medical Officer

Clinical Research Manager

DAIDS Clinical Representative

Data Manager

Drug Co. Representative

Field Representative

Laboratory Data Manager (LDM)

Laboratory Technologist

Medical Officer

Pharmaceutical Company Representative

Pharmacologist

Manuscripts

Abstracts

Impact of maternal tenofovir use on HIV exposed newborn bone mineral

Conference

CROI 2016

Study

P1084s

Authors

GK Siberry, C Tierney , L Stranix-Chibanda, C Marr, JA Shepherd, R Browning, H Kalkwarf, K George, MG Fowler for the IMPAACT P1084s team

Reflection analysis of infant scans results may improve infant DXA bone density and body composition result that contain motion

Conference

16th International Conference of Infectious Diseases

Study

P1084s